Expert Discussion: Active Surveillance vs. Focal Therapy for Low-risk Prostate Cancer
Βy: Laurence Klotz (Canada), Inderbir Gill (United States of America)
SIU Academy®. Presenters F. 12/01/13; 55513
Topic: ResearchΒy: Laurence Klotz (Canada), Inderbir Gill (United States of America)
Laurence Klotz
Inderbir Gill
REGULAR CONTENT
Login now to access Regular content available to all registered users.
To have an exclusive access to the entire content available on SIU Academy, become an SIU Member here.
To have an exclusive access to the entire content available on SIU Academy, become an SIU Member here.
Learning Objectives
Discussion Forum (0)
Rate & Comment (0)
Upon viewing this debate, the participant will be able to:
• Explain the rationale for active surveillance and focal therapy
• Outline the role of patient selection and monitoring in the management of low-risk prostate cancer
• Explain the rationale for active surveillance and focal therapy
• Outline the role of patient selection and monitoring in the management of low-risk prostate cancer
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}